Green Bay, WI (BUSINESS WIRE) - As fleets face mounting regulatory and reporting expectations, from new emissions standards to heightened compliance scrutiny, Breakthrough, a leader in transportation ...

Self-driving cars that glide through cities without ever hitting traffic, virtual doctors diagnosing you instantly at home, and the ability to feel the touch of someone thousands of miles away may ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands First Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – ...

Led by cornerstone investors Alaska Airlines, American Airlines; with IAG, Cathay Pacific, Japan Airlines from oneworld alliance, and Singapore Airlines as part of initial $150M fund close oneworld ...

The biggest criticism against the vegan diet is that some claim it lacks the nutritional value of an omnivorous diet, but one company is changing that narrative with nutritionally comparable ...

Blue Origin notched a major milestone Thursday as its massive New Glenn rocket lifted off from Cape Canaveral and successfully sent a pair of NASA spacecraft on their long trajectory toward Mars — ...

$50,000 award will grant access to LabCentral's lab space, shared resources, and community to one early-stage biotech company working to treat or cure type 1 diabetes. CAMBRIDGE, Mass. , Aug. 5, 2025 ...

Jeff Bezos's space firm Blue Origin has successfully launched its New Glenn rocket from Cape Canaveral on Thursday, sending two NASA spacecraft on a mission to study Mars and completing a breakthrough ...

The Oneworld airline alliance has partnered with Breakthrough Energy Ventures to launch a new investment fund to "accelerate the global development of long-term aviation fuel solutions that are cost ...

First patient implanted with Genio at Saudi German Hospital in Dubai, United Arab Emirates Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA). We are a ...

$50,000 award will grant access to LabCentral's lab space, shared resources, and community to one early-stage biotech company working to treat or cure type 1 diabetes. As part of a first-of-its-kind ...